Skip to main content

Advertisement

Log in

The Relationship Between Patient Knowledge of Hemoglobin Levels and Health-Related Quality of Life

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Background: An anti-anemia drug may improve self-reported quality of life (QOL) partly because patients know their hemoglobin level is rising. In the absence of any published studies on this topic, the authors investigated the association between knowledge of hemoglobin levels and self-reported QOL.Methods: The study analyzed health-related QOL (HRQOL) data from five randomized clinical trials of erythropoietic therapy in patients with cancer-related anemia. Patients were asked whether they knew their hemoglobin level and, if so, to report its value. Patients (n = 1007) were grouped into three categories depending on the extent and accuracy of hemoglobin level knowledge. HRQOL scale scores were compared between categories.Results: Only 23.2% of patients reported knowing their hemoglobin level at the end of the study; however, the value was accurate (within 1 g/dl) in 88.0% of these patients. On five of the 11 HRQOL scales studied, there was a significant association between knowledge of hemoglobin level and HRQOL score. However, the magnitude of the mean difference between those who knew vs. those who did not know their hemoglobin was generally below scale thresholds for minimally important differences. Conclusions: Patient knowledge of hemoglobin level has a modest association with some aspects of self-reported HRQOL. The magnitude of this association, where it exists, would be unlikely to explain large group differences in HRQOL reports over time, even for patients who know their hemoglobin level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. A Bottomley R Thomas K Steen Particlevan H Flechtner B Djulbegovic (2002) ArticleTitleHuman recombinant erythropoietin and quality of life: a wonder drug or something to wonder about? Lancet Oncol 3 145–153 Occurrence Handle1:CAS:528:DC%2BD38Xis1aksLw%3D Occurrence Handle11902500

    CAS  PubMed  Google Scholar 

  2. I Wiklund H Glise P Jerndal J Carlsson NJ Talley (1998) ArticleTitleDoes endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc 47 449–454 Occurrence Handle10.1016/S0016-5107(98)70243-3 Occurrence Handle1:STN:280:DyaK1czgvFGrsA%3D%3D Occurrence Handle9647367

    Article  CAS  PubMed  Google Scholar 

  3. FJ Mena-Martin JC Martin-Escudero F Simal-Blanco JL Carretero-Ares D Arzua-Mouronte V Herreros- Fernandez (2003) ArticleTitleHealth-related quality of life of subjects with known and unknown hypertension: results from the population-based Hortega study J Hypertens 21 1283–1289 Occurrence Handle10.1097/00004872-200307000-00015 Occurrence Handle1:CAS:528:DC%2BD3sXmsVaitLY%3D Occurrence Handle12817174

    Article  CAS  PubMed  Google Scholar 

  4. S Kreitler S Chaitchik Y Rapoport R Algor (1995) ArticleTitlePsychosocial effects of level of information and severity of disease on head-and-neck cancer patients J Cancer Educ 10 144–154 Occurrence Handle1:STN:280:BymC383jsVU%3D Occurrence Handle8534601

    CAS  PubMed  Google Scholar 

  5. JA Glaspy JS Jadeja G Justice et al. (2002) ArticleTitleDarbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy Br J Cancer 87 268–276 Occurrence Handle10.1038/sj.bjc.6600465 Occurrence Handle1:CAS:528:DC%2BD38XmtVOntb4%3D Occurrence Handle12177793

    Article  CAS  PubMed  Google Scholar 

  6. JA Glaspy JS Jadeja G Justice A Fleishman G Rossi AB Colowick (2003) ArticleTitleA randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease Cancer 97 1312–1320 Occurrence Handle1:CAS:528:DC%2BD3sXisVKhur0%3D Occurrence Handle12599240

    CAS  PubMed  Google Scholar 

  7. J Vansteenkiste R Pirker B Massuti et al. (2002) ArticleTitleDouble-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy J Natl Cancer Inst 94 1211–1220 Occurrence Handle1:CAS:528:DC%2BD38XntVyjs7c%3D Occurrence Handle12189224

    CAS  PubMed  Google Scholar 

  8. RE Smith NS Tchekmedyian D Chan LA Meza DW Northfelt R Patel et al. (2003) ArticleTitleA dose-finding and schedule-finding study of darbepoetin alfa for the treatment of chronic anaemia of cancer Br J Cancer 88 1851–1888 Occurrence Handle10.1038/sj.bjc.6600994 Occurrence Handle1:CAS:528:DC%2BD3sXksVKjtb0%3D Occurrence Handle12799626

    Article  CAS  PubMed  Google Scholar 

  9. M Hedenus M Adriansson J San Miguel et al. (2003) ArticleTitleEfficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study Br J Haematol 122 394–403 Occurrence Handle10.1046/j.1365-2141.2003.04448.x Occurrence Handle1:CAS:528:DC%2BD3sXmvFyns7o%3D Occurrence Handle12877666

    Article  CAS  PubMed  Google Scholar 

  10. D Cella (1997) ArticleTitleThe Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue Semin Hematol 34 13–19 Occurrence Handle1:STN:280:ByiA1MjptlY%3D Occurrence Handle9253779

    CAS  PubMed  Google Scholar 

  11. SB Yellen DF Cella K Webster C Blendowski E Kaplan (1997) ArticleTitleMeasuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system J Pain Symptom Manage 13 63–74 Occurrence Handle10.1016/S0885-3924(96)00274-6 Occurrence Handle1:STN:280:ByiB2cbntVQ%3D Occurrence Handle9095563

    Article  CAS  PubMed  Google Scholar 

  12. D Cella EA Hahn K Dineen (2002) ArticleTitleMeaningful change in cancer-specific quality of life scores: differences between improvement and worsening Qual Life Res 11 207–221 Occurrence Handle10.1023/A:1015276414526 Occurrence Handle12074259

    Article  PubMed  Google Scholar 

  13. D Cella D Elton JS Lai (2002) ArticleTitleCombining anchor and distribution based methods to derive clinically meaningful differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue scales J Pain Symptom Manage 24 547–561 Occurrence Handle10.1016/S0885-3924(02)00529-8 Occurrence Handle12551804

    Article  PubMed  Google Scholar 

  14. DL Patrick DD Gagnon MJ Zagari R Mathijs J Sweetenham (2003) ArticleTitleAssessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa Eur J Cancer 39 335–345 Occurrence Handle10.1016/S0959-8049(02)00628-7 Occurrence Handle1:CAS:528:DC%2BD3sXotlCrtA%3D%3D Occurrence Handle12565986

    Article  CAS  PubMed  Google Scholar 

  15. I Quirt C Robeson CY Lau et al. (2002) ArticleTitleEpoetin alfa in patients not on chemotherapy – Canadian data Semin Oncol 29 75–80 Occurrence Handle1:CAS:528:DC%2BD38XlsF2hsb8%3D Occurrence Handle12082658

    CAS  PubMed  Google Scholar 

  16. D Cella JS Lai CH Chang A Peterman M Slavin (2002) ArticleTitleFatigue in cancer patients compared with fatigue in the general United States population Cancer 94 528–538 Occurrence Handle10.1002/cncr.10245 Occurrence Handle11900238

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Kallich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kallich, J., McDermott, A., Xu, X. et al. The Relationship Between Patient Knowledge of Hemoglobin Levels and Health-Related Quality of Life. Qual Life Res 15, 57–68 (2006). https://doi.org/10.1007/s11136-005-8324-0

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-005-8324-0

Keywords

Navigation